IM
Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ·Healthcare·Biotechnology
$4.21
+9.64%
Mkt Cap $154.79M
Analyst Ratings
No recent rating data.
Price Target (10 analysts)
$10.50
Range $9.00 – $12.00
Implied Upside
+149.4%
Consensus $10.50 vs current $4.21